Assorted News from the Last Week:

This edition of the CAC2 blog post addresses the needs of children impacted by an education interruption due to a rare disease, like childhood cancer, from diagnosis through survivorship.

Exercise boosts recovery in pediatric cancer patients.

Childhood cancer survivors who were exposed to heart radiation therapy or high cumulative anthracycline doses face increased risks for valvular heart disease. Greater exposure to platinum-based agents may be a risk factor as well.

New research reveals genetic link to most common pediatric bone cancer.

Repeated brain tumor sampling uncovers treatment response in patients with glioblastoma.

A feasible path to spotting financial and social hardship in childhood cancer care.

On Oct. 7, U.S. News & World Report released its annual rankings of pediatric hospitals, including the top children’s hospitals for treating cancer.

Upcoming Webinars, Online Opportunities, and Meetings:

The Science of Childhood Cancer is an interactive, weekly lecture series designed to engage the scientific community on key questions in pediatric cancer research. The Fall 2025 lecture season will run August 14 through November 20. Click here for more information and to register.

Eureka Therapeutics hosts a special webinar on Hepatoblastoma: After Hepatoblastoma- A Parent and Nurse Perspective, featuring Julie Chessell, RN: nurse, parent advocate, and volunteer with the Hepatoblastoma Resource Network. Click here for more information and to register.

Action Days 2026 will be held in Washington, D.C. from February 24-25, 2026. Registration is open! Action Days registration will close on Friday, January 30, or when we reach 225 participants. Click here for more information and to register.